AI assistant
Sending…
REPLIGEN CORP — Director's Dealing 2017
Jul 20, 2017
30826_dirs_2017-07-20_6ed0993b-18cc-4837-a9c1-e9285d0e3d74.zip
Director's Dealing
Open in viewerOpens in your device viewer
SEC Form 4 — Statement of Changes in Beneficial Ownership
Issuer: REPLIGEN CORP (RGEN)
CIK: 0000730272
Period of Report: 2017-07-18
Reporting Person: Snodgres Jon (CFO)
Non-Derivative Transactions
| Date | Security | Code | Shares | Price | A/D | Holdings After | Ownership |
|---|---|---|---|---|---|---|---|
| 2017-07-18 | Common Stock | F | 345 | $41.77 | Disposed | 27444 | Direct |
Footnotes
F1: Payment of tax liability made via forfeiture of 345 shares of Common Stock valued at a price of $41.77 per share on July 18, 2017.
More from REPLIGEN CORP
Regulatory Filings
2026
May 15
Interim / Quarterly Report
2026
May 6
Regulatory Filings
2026
May 5
Proxy Solicitation & Information Statement
2026
Apr 27
Annual Report
2026
Apr 2
Proxy Solicitation & Information Statement
2026
Apr 2
Proxy Solicitation & Information Statement
2026
Apr 2
Major Shareholding Notification
2026
Mar 27
Director's Dealing
2026
Mar 23
Director's Dealing
2026
Mar 23